Subscribe
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma
Issues
2013
July 2013, Vol 4, No 6
July 2013, Vol 4, No 6
CVS Caremark Value Proposition for Oncology Pharmacy
By
Caroline Helwick
July 2013, Vol 4, No 6
Hollywood, FL—In response to mandates for more efficient and lower-cost cancer drug utilization, CVS Caremark is developing innovative strategies, said Kirby J. Eng, RPh, Director of Oncology Medical Pharmacy Management, CVS Caremark, at the Third Annual Conference of the Association for Value-Based Cancer Care.
Read Article
Adenoma Detection Rates in Colonoscopy: The Higher the Better
By
Caroline Helwick
Colorectal Cancer
,
Personalized Medicine
July 2013, Vol 4, No 6
Orlando, FL—In screening colonoscopies, high adenoma detection rates (ADRs) by physicians are associated with fewer missed cancers and with better survival from colorectal cancer (CRC), according to 2 studies presented at Digestive Disease Week 2013.
Read Article
Assessing the Value of New, Costly Radiation Therapies in Older Patients with Breast Cancer
By
Caroline Helwick
Economics & Value
,
Economics of Cancer Care
July 2013, Vol 4, No 6
Chicago, IL—For-profit hospitals are more likely than their nonprofit counterparts to treat elderly patients with breast cancer with an expensive form of radiotherapy—despite lacking evidence of its benefit, researchers from the Yale Cancer Outcomes, Public Policy and Effectiveness Research Center reported at the 2013 American Society of Clinical Oncology annual meeting.
Read Article
Can We Afford to Make Progress in Cancer Care? The Economics of Drug Development
By
Caroline Helwick
Economics & Value
,
Economics of Cancer Care
July 2013, Vol 4, No 6
Chicago, IL—The rapid advances in cancer treatment, especially in personalized medicine, are occurring at an enormous financial cost to the healthcare system.
Read Article
ASCO President Highlights Bridges to Conquer Cancer
By
Wayne Kuznar
Economics & Value
,
Economics of Cancer Care
July 2013, Vol 4, No 6
Chicago, IL—“Building Bridges to Conquer Cancer” was the theme of the 2013 American Society of Clinical Oncology (ASCO) annual meeting, as well as of the address of ASCO’s outgoing President Sandra M. Swain, MD.
Read Article
Consolidation in Cancer Care Delivery System: The Impact on Quality and Cost
By
Craig Deligdish, MD
From the Editor
,
Value Peer-spectives
July 2013, Vol 4, No 6
The past several years have seen significant consolidation in the healthcare industry. The cost of healthcare in the United States is currently estimated to be 18% of the gross domestic product (GDP), and the costs are projected to increase disproportionately to the GDP during the next decade.
Read Article
Researchers Discover a Set of Proteins that Cause Many Cancer-Related Mutations
Value Propositions
,
Value Peer-spectives
July 2013, Vol 4, No 6
A new study led by researchers at the National Institutes of Health shows that a set of proteins in the body produces a large number of mutations in human DNA, indicating that these naturally produced mutations are just as powerful as cancer-causing agents in producing tumors.
Read Article
The Promise of Immunotherapy in the Race to Cure Cancer
Value Propositions
,
Value Peer-spectives
July 2013, Vol 4, No 6
Many presentations at the 2013 annual meeting of the American Society of Clinical Oncology (ASCO) focused on new research involving immunotherapy, including drugs for melanoma and lung cancer that have shown great success in prolonging life in patients with advanced disease.
Read Article
Quality Measures Are Increasingly Tied to Physician Reimbursement
Value Propositions
,
Value Peer-spectives
July 2013, Vol 4, No 6
Quality measures and patient satisfaction are increasingly being tied to a proportion of physicians’ reimbursement, according to a new report from the Medical Group Management Association-American College of Medical Practice Executives (MGMA-ACMPE), “Physician Compensation and Production Survey: 2013 Report Based on 2012 Data.”
Read Article
Senate Bill Designates $251.9 Million for Electronic Health Records for the VA System
Value Propositions
,
Value Peer-spectives
July 2013, Vol 4, No 6
The new US Senate bill for the Veterans Affairs (VA) system provides $3.7 billion for the VA System information technology, which includes $251.9 million for an integrated electronic health record system and $119.4 million for the Veterans Benefits Management System claims systems.
Read Article
Page 2 of 3
1
2
3
View the Latest Issue of VBCC
Read Issue
Top Trending Articles
1.
Navigating the Complex Landscape of Oral Cancer Medication
2.
Luspatercept Yields Improved Transfusion Independence Compared With Epoetin Alfa in Patients With Lower-Risk MDS
Phoebe Starr
3.
Talvey Receives Accelerated Approval for Relapsed or Refractory Multiple Myeloma
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma